Activity value 75india Supplier,Last transaction date:
2026-03-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zoripharm international from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 29 transactions, with a transaction quantity of 2870548.6 and a transaction weight of 83403.52.
2amedex
costa ricabuyer,they trade on 2026-02-06
188.57%
>
3not specified
costa ricasupplier,they trade on 2026-02-20
178.10%
>
Products
Total 3
ProductsTransactionsPerDetail
trastuzumab 3371.74%>
doxycycline 3371.74%>
drug rofiprofen 1226.09%>
Hscode rank
Total 3
HSCode NameTransactionsPerDetail
HS 3004909100903371.74%>
HS 3004201000001226.09%>
HS 30041010009012.17%>
Trading Area
Total 1
AreaTransactionsPerDetail
costa rica18990.00%>
zoripharm international is india Supplier,
and primarily engages in the import and export business of products such as trastuzumab,doxycycline,drug rofiprofen.
According to the 52wmb.com global trade database, as of 2026-03-30, the company has completed 210 international trades,
with its main trading regions covering costa rica etc.
The core products include HS300490910090,HS300420100000,HS300410100090 etc,
and its main trading partners are panamedical de costa rica s.a.,amedex,not specified.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zoripharm international is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.